{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:43:56Z","timestamp":1790725436031,"version":"4.1.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T00:00:00Z","timestamp":1435968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T00:00:00Z","timestamp":1435968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s12016-015-8499-2","type":"journal-article","created":{"date-parts":[[2015,7,3]],"date-time":"2015-07-03T06:23:33Z","timestamp":1435904613000},"page":"303-314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Impact of Immunoglobulin Therapy in Pediatric Disease: a Review of Immune Mechanisms"],"prefix":"10.1007","volume":"51","author":[{"given":"Priscilla H.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,4]]},"reference":[{"issue":"6","key":"8499_CR1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.9.6.722","volume":"9","author":"OC Bruton","year":"1952","unstructured":"Bruton OC (1952) Agammaglobulinemia. Pediatrics 9(6):722\u2013728","journal-title":"Pediatrics"},{"key":"8499_CR2","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1055\/s-0029-1207589","volume":"16","author":"EAK Behring","year":"1890","unstructured":"Behring EAK, Ueber S (1890) das zustandekommen der diphtherie-immunitat und der tetanus-immunitat bei thieren. Dtsch Med Wochenschr 16:1113\u20131114","journal-title":"Dtsch Med Wochenschr"},{"issue":"21","key":"8499_CR3","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1056\/NEJMra1009433","volume":"367","author":"EW Gelfand","year":"2012","unstructured":"Gelfand EW (2012) Intravenous immune globulin in autoimmune and inflammatory diseases. N Engl J Med 367(21):2015\u20132025","journal-title":"N Engl J Med"},{"issue":"Suppl 5","key":"8499_CR4","doi-asserted-by":"publisher","first-page":"V18","DOI":"10.1007\/s00415-006-5003-1","volume":"253","author":"M Stangel","year":"2006","unstructured":"Stangel M, Pul R (2006) Basic principles of intravenous immunoglobulin (IVIg) treatment. J Neurol 253(Suppl 5):V18\u2013V24","journal-title":"J Neurol"},{"issue":"1","key":"8499_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1136\/archdischild-2012-302841","volume":"99","author":"D Eleftheriou","year":"2014","unstructured":"Eleftheriou D et al (2014) Management of Kawasaki disease. Arch Dis Childhood 99(1):74\u201383","journal-title":"Arch Dis Childhood"},{"issue":"6","key":"8499_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.autrev.2009.12.004","volume":"9","author":"C Galeotti","year":"2010","unstructured":"Galeotti C et al (2010) Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin. Autoimmun Rev 9(6):441\u2013448","journal-title":"Autoimmun Rev"},{"issue":"7","key":"8499_CR7","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1007\/s00246-012-0229-4","volume":"33","author":"K Kaneko","year":"2012","unstructured":"Kaneko K et al (2012) Intravenous immunoglobulin counteracts oxidative stress in Kawasaki disease. Pediatr Cardiol 33(7):1086\u20131088","journal-title":"Pediatr Cardiol"},{"issue":"22","key":"8499_CR8","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","volume":"113","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T et al (2006) Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113(22):2606\u20132612","journal-title":"Circulation"},{"issue":"9","key":"8499_CR9","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1073\/pnas.89.9.4066","volume":"89","author":"J Abe","year":"1992","unstructured":"Abe J et al (1992) Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A 89(9):4066\u20134070","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1 Suppl 57","key":"8499_CR10","first-page":"93","volume":"28","author":"B Olivito","year":"2010","unstructured":"Olivito B et al (2010) Defective FOXP3 expression in patients with acute Kawasaki disease and restoration by intravenous immunoglobulin therapy. Clin Exp Rheumatol 28(1 Suppl 57):93\u201397","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"8499_CR11","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.4049\/jimmunol.174.9.5837","volume":"174","author":"J Abe","year":"2005","unstructured":"Abe J et al (2005) Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease. J Immunol 174(9):5837\u20135845","journal-title":"J Immunol"},{"issue":"4","key":"8499_CR12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1399-3038.2007.00516.x","volume":"18","author":"HC Kuo","year":"2007","unstructured":"Kuo HC et al (2007) The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease. Pediatr Allergy Immunol: Off Publ Eur Soc Pediatr Allergy Immunol 18(4):354\u2013359","journal-title":"Pediatr Allergy Immunol: Off Publ Eur Soc Pediatr Allergy Immunol"},{"issue":"3","key":"8499_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1046\/j.1468-0734.2001.00040.x","volume":"5","author":"H Gadner","year":"2001","unstructured":"Gadner H (2001) Management of immune thrombocytopenic purpura in children. Rev Clin Exp Hematol 5(3):201\u2013221, discussion 311-2","journal-title":"Rev Clin Exp Hematol"},{"issue":"8","key":"8499_CR14","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/00043426-200308000-00017","volume":"25","author":"LJ Butros","year":"2003","unstructured":"Butros LJ, Bussel JB (2003) Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis. J Pediatr Hematol Oncol 25(8):660\u2013664","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"8499_CR15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1542\/peds.111.1.87","volume":"111","author":"D Holt","year":"2003","unstructured":"Holt D et al (2003) Response to intravenous immunoglobulin predicts splenectomy response in children with immune thrombocytopenic purpura. Pediatrics 111(1):87\u201390","journal-title":"Pediatrics"},{"issue":"6","key":"8499_CR16","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1365-2141.2009.07717.x","volume":"146","author":"D Nugent","year":"2009","unstructured":"Nugent D et al (2009) Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and\/or decreased platelet production. Br J Haematol 146(6):585\u2013596","journal-title":"Br J Haematol"},{"issue":"2","key":"8499_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ajh.2830480207","volume":"48","author":"JW Taub","year":"1995","unstructured":"Taub JW et al (1995) Characterization of autoantibodies against the platelet glycoprotein antigens IIb\/IIIa in childhood idiopathic thrombocytopenia purpura. Am J Hematol 48(2):104\u2013107","journal-title":"Am J Hematol"},{"issue":"4","key":"8499_CR18","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1182\/blood-2003-08-2672","volume":"103","author":"R McMillan","year":"2004","unstructured":"McMillan R et al (2004) Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 103(4):1364\u20131369","journal-title":"Blood"},{"issue":"16","key":"8499_CR19","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1056\/NEJMoa054626","volume":"355","author":"JB Bussel","year":"2006","unstructured":"Bussel JB et al (2006) AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med 355(16):1672\u20131681","journal-title":"N Engl J Med"},{"issue":"8232","key":"8499_CR20","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/S0140-6736(81)92400-4","volume":"1","author":"P Imbach","year":"1981","unstructured":"Imbach P et al (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1(8232):1228\u20131231","journal-title":"Lancet"},{"issue":"3-4","key":"8499_CR21","first-page":"133","volume":"50","author":"RJ Hansen","year":"2004","unstructured":"Hansen RJ, Balthasar JP (2004) Mechanisms of IVIG action in immune thrombocytopenic purpura. Clin Lab 50(3-4):133\u2013140","journal-title":"Clin Lab"},{"issue":"10","key":"8499_CR22","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1191\/0961203303lu2168rr","volume":"14","author":"U Katz","year":"2005","unstructured":"Katz U, Shoenfeld Y (2005) Review: intravenous immunoglobulin therapy and thromboembolic complications. Lupus 14(10):802\u2013808","journal-title":"Lupus"},{"issue":"1","key":"8499_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/pbc.22968","volume":"57","author":"AZ Al-Riyami","year":"2011","unstructured":"Al-Riyami AZ et al (2011) Cerebral sinus thrombosis following IV immunoglobulin therapy of immune thrombocytopenia purpura. Pediatr Blood Cancer 57(1):157\u2013159","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"8499_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/01.mph.0000155871.26380.84","volume":"27","author":"AE Niebanck","year":"2005","unstructured":"Niebanck AE, Kwiatkowski JL, Raffini LJ (2005) Neutropenia following IVIG therapy in pediatric patients with immune-mediated thrombocytopenia. J Pediatr Hematol Oncol 27(3):145\u2013147","journal-title":"J Pediatr Hematol Oncol"},{"key":"8499_CR25","volume":"7","author":"RA Hughes","year":"2012","unstructured":"Hughes RA, Swan AV, van Doorn PA (2012) Intravenous immunoglobulin for Guillain-Barre syndrome. Cochrane Database Syst Rev 7, CD002063","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"8499_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1067\/mpd.2003.115","volume":"142","author":"J Vajsar","year":"2003","unstructured":"Vajsar J, Fehlings D, Stephens D (2003) Long-term outcome in children with Guillain-Barre syndrome. J Pediatr 142(3):305\u2013309","journal-title":"J Pediatr"},{"issue":"6","key":"8499_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/0923-2494(92)80040-R","volume":"143","author":"G Said","year":"1992","unstructured":"Said G, Hontebeyrie-Joskowicz M (1992) Nerve lesions induced by macrophage activation. Res Immunol 143(6):589\u2013599","journal-title":"Res Immunol"},{"issue":"2","key":"8499_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/mus.880180202","volume":"18","author":"HP Hartung","year":"1995","unstructured":"Hartung HP et al (1995) Immunopathogenesis and treatment of the Guillain-Barre syndrome\u2014part I. Muscle Nerve 18(2):137\u2013153","journal-title":"Muscle Nerve"},{"issue":"6","key":"8499_CR29","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1136\/jnnp.51.6.820","volume":"51","author":"M Cruz","year":"1988","unstructured":"Cruz M et al (1988) Occurrence and isotype of antibodies against peripheral nerve myelin in serum from patients with peripheral neuropathy and healthy controls. J Neurol Neurosurg Psychiatry 51(6):820\u2013825","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"8499_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/mus.880180203","volume":"18","author":"HP Hartung","year":"1995","unstructured":"Hartung HP et al (1995) Immunopathogenesis and treatment of the Guillain-Barre syndrome\u2014part II. Muscle Nerve 18(2):154\u2013164","journal-title":"Muscle Nerve"},{"issue":"11","key":"8499_CR31","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1177\/08830738030180110501","volume":"18","author":"R Koul","year":"2003","unstructured":"Koul R et al (2003) Ten-year prospective study (clinical spectrum) of childhood Guillain-Barre syndrome in the Arabian peninsula: comparison of outcome in patients in the pre- and post-intravenous immunoglobulin eras. J Child Neurol 18(11):767\u2013771","journal-title":"J Child Neurol"},{"issue":"11","key":"8499_CR32","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1177\/08830738060210110701","volume":"21","author":"HA Tasdemir","year":"2006","unstructured":"Tasdemir HA et al (2006) Intravenous immunoglobulin for Guillain-Barre syndrome: how effective? J Child Neurol 21(11):972\u2013974","journal-title":"J Child Neurol"},{"issue":"Pt 9","key":"8499_CR33","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/brain\/120.9.1533","volume":"120","author":"CM Gabriel","year":"1997","unstructured":"Gabriel CM et al (1997) Human immunoglobulin ameliorates rat experimental autoimmune neuritis. Brain: J Neurol 120(Pt 9):1533\u20131540","journal-title":"Brain: J Neurol"},{"issue":"Suppl","key":"8499_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/jnnp.57.Suppl.65","volume":"57","author":"BG van Engelen","year":"1994","unstructured":"van Engelen BG et al (1994) Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis. J Neurol Neurosurg Psychiatry 57(Suppl):65\u201368","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"8499_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0304-3940(99)00782-X","volume":"275","author":"T Kuhlmann","year":"1999","unstructured":"Kuhlmann T, Bruck W (1999) Immunoglobulins induce increased myelin debris clearance by mouse macrophages. Neurosci Lett 275(3):191\u2013194","journal-title":"Neurosci Lett"},{"issue":"1","key":"8499_CR36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0146-0005(98)80007-4","volume":"22","author":"HB Jenson","year":"1998","unstructured":"Jenson HB, Pollock BH (1998) The role of intravenous immunoglobulin for the prevention and treatment of neonatal sepsis. Semin Perinatol 22(1):50\u201363","journal-title":"Semin Perinatol"},{"issue":"4","key":"8499_CR37","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0095-5108(18)30672-9","volume":"15","author":"JE Baley","year":"1988","unstructured":"Baley JE (1988) Neonatal sepsis: the potential for immunotherapy. Clin Perinatol 15(4):755\u2013771","journal-title":"Clin Perinatol"},{"key":"8499_CR38","volume":"7","author":"RF Soll","year":"2013","unstructured":"Soll RF (2013) Calling time on intravenous immunoglobulin for preterm infants? Cochrane Database System Rev 7, ED000062","journal-title":"Cochrane Database System Rev"},{"key":"8499_CR39","volume":"7","author":"A Ohlsson","year":"2013","unstructured":"Ohlsson A, Lacy JB (2013) Intravenous immunoglobulin for preventing infection in preterm and\/or low birth weight infants. Cochrane Database Syst Rev 7, CD000361","journal-title":"Cochrane Database Syst Rev"},{"issue":"8382","key":"8499_CR40","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/S0140-6736(84)91376-X","volume":"1","author":"AS Cross","year":"1984","unstructured":"Cross AS et al (1984) Intravenous immune globulin: a cautionary note. Lancet 1(8382):912","journal-title":"Lancet"},{"issue":"5","key":"8499_CR41","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1067\/mpd.2000.109791","volume":"137","author":"K Sandberg","year":"2000","unstructured":"Sandberg K et al (2000) Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. J Pediatr 137(5):623\u2013628","journal-title":"J Pediatr"},{"issue":"Suppl 1","key":"8499_CR42","first-page":"73","volume":"97","author":"GW Fischer","year":"1994","unstructured":"Fischer GW (1994) Use of intravenous immune globulin in newborn infants. Clin Exp Immunol 97(Suppl 1):73\u201377","journal-title":"Clin Exp Immunol"},{"issue":"13","key":"8499_CR43","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa1100441","volume":"365","author":"P Brocklehurst","year":"2011","unstructured":"Brocklehurst P et al (2011) Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med 365(13):1201\u20131211","journal-title":"N Engl J Med"},{"issue":"10","key":"8499_CR44","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/jp.2009.197","volume":"30","author":"JL Wynn","year":"2010","unstructured":"Wynn JL, Seed PC, Cotten CM (2010) Does IVIg administration yield improved immune function in very premature neonates? J Perinatol 30(10):635\u2013642","journal-title":"J Perinatol"},{"issue":"1","key":"8499_CR45","doi-asserted-by":"publisher","first-page":"F46","DOI":"10.1136\/fn.78.1.F46","volume":"78","author":"J Kallman","year":"1998","unstructured":"Kallman J et al (1998) Impaired phagocytosis and opsonisation towards group B streptococci in preterm neonates. Archives of disease in childhood. Fetal Neonatal Ed 78(1):F46\u2013F50","journal-title":"Fetal Neonatal Ed"},{"issue":"1","key":"8499_CR46","first-page":"27","volume":"10","author":"HA Lassiter","year":"1990","unstructured":"Lassiter HA et al (1990) Complement C3 deposition onto bacteria by neonatal serum is not enhanced after the infusion of intravenous immunoglobulin. J Perinatol: Off J California Perinatal Assoc 10(1):27\u201331","journal-title":"J Perinatol: Off J California Perinatal Assoc"},{"key":"8499_CR47","unstructured":"UNAIDS Report on the Global AIDS Epidemic, 2012 (2012 04 June 2014]; Available from: http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/epidemiology\/2012\/gr2012\/20121120_UNAIDS_Global_Report_2012_with_annexes_en.pdf"},{"issue":"1 Suppl","key":"8499_CR48","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1203\/00006450-199333011-00015","volume":"33","author":"LM Mofenson","year":"1993","unstructured":"Mofenson LM, Moye J Jr (1993) Intravenous immune globulin for the prevention of infections in children with symptomatic human immunodeficiency virus infection. Pediatr Res 33(1 Suppl):S80\u2013S87, discussion S87-9","journal-title":"Pediatr Res"},{"issue":"8","key":"8499_CR49","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.4049\/jimmunol.138.8.2640","volume":"138","author":"DL Mann","year":"1987","unstructured":"Mann DL et al (1987) HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. J Immunol 138(8):2640\u20132644","journal-title":"J Immunol"},{"issue":"2 Suppl","key":"8499_CR50","first-page":"S138","volume":"18","author":"S Pahwa","year":"1990","unstructured":"Pahwa S (1990) Immune defects in pediatric AIDS, their pathogenesis, and role of immunotherapy. Crit Care Med 18(2 Suppl):S138\u2013S143","journal-title":"Crit Care Med"},{"issue":"10","key":"8499_CR51","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.1073\/pnas.0730819100","volume":"100","author":"S Moir","year":"2003","unstructured":"Moir S et al (2003) Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals. Proc Natl Acad Sci U S A 100(10):6057\u20136062","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"8499_CR52","doi-asserted-by":"publisher","first-page":"e315","DOI":"10.1542\/peds.2005-2616","volume":"118","author":"V Bekker","year":"2006","unstructured":"Bekker V et al (2006) Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection. Pediatrics 118(2):e315\u2013e322","journal-title":"Pediatrics"},{"issue":"4 Pt 2","key":"8499_CR53","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/0091-6749(89)90201-7","volume":"84","author":"S Pahwa","year":"1989","unstructured":"Pahwa S (1989) Intravenous immune globulin in patients with acquired immune deficiency syndrome. J Allergy Clin Immunol 84(4 Pt 2):625\u2013630, discussion 630-1","journal-title":"J Allergy Clin Immunol"},{"key":"8499_CR54","unstructured":"Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR. Morbidity and mortality weekly report, 1987. 36(15): p. 225-30, 235-6"},{"issue":"4","key":"8499_CR55","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.iac.2008.06.001","volume":"28","author":"A Deener","year":"2008","unstructured":"Deener A et al (2008) Intravenous gammaglobulin treatment in HIV-1 infection. Immunol Allergy Clin North Am 28(4):851\u2013859, x","journal-title":"Immunol Allergy Clin North Am"},{"key":"8499_CR56","doi-asserted-by":"crossref","unstructured":"Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. The National Institute of Child Health and Human Developments Intravenous Immunoglobulin Study Group. N Engl J Med, 1991. 325(2): p. 73-80","DOI":"10.1056\/NEJM199107113250201"},{"issue":"18","key":"8499_CR57","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1056\/NEJM199411033311802","volume":"331","author":"SA Spector","year":"1994","unstructured":"Spector SA et al (1994) A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. N Engl J Med 331(18):1181\u20131187","journal-title":"N Engl J Med"},{"issue":"2","key":"8499_CR58","first-page":"115","volume":"12","author":"K van Rijckevorsel","year":"1999","unstructured":"van Rijckevorsel K (1999) Immunological mechanisms in the aetiology of epilepsy: implications for treatment. Bio Drugs: Clin Immunother Biopharmaceuticals Gene Ther 12(2):115\u2013127","journal-title":"Bio Drugs: Clin Immunother Biopharmaceuticals Gene Ther"},{"issue":"4 Suppl","key":"8499_CR59","doi-asserted-by":"publisher","first-page":"S525","DOI":"10.1016\/j.jaci.2006.01.015","volume":"117","author":"JS Orange","year":"2006","unstructured":"Orange JS et al (2006) Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 117(4 Suppl):S525\u2013S553","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 3","key":"8499_CR60","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1528-1167.2011.03031.x","volume":"52","author":"CG Bien","year":"2011","unstructured":"Bien CG, Scheffer IE (2011) Autoantibodies and epilepsy. Epilepsia 52(Suppl 3):18\u201322","journal-title":"Epilepsia"},{"issue":"6","key":"8499_CR61","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.pediatrneurol.2012.03.015","volume":"46","author":"K Geva-Dayan","year":"2012","unstructured":"Geva-Dayan K et al (2012) Immunoglobulin treatment for severe childhood epilepsy. Pediatric Neurol 46(6):375\u2013381","journal-title":"Pediatric Neurol"},{"issue":"Suppl 1","key":"8499_CR62","first-page":"71","volume":"104","author":"M Duse","year":"1996","unstructured":"Duse M et al (1996) Intravenous immune globulin in the treatment of intractable childhood epilepsy. Clin Exp Immunol 104(Suppl 1):71\u201376","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"8499_CR63","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1111\/j.1528-1167.2007.01134.x","volume":"48","author":"AD Billiau","year":"2007","unstructured":"Billiau AD et al (2007) Intravenous immunoglobulins in refractory childhood-onset epilepsy: effects on seizure frequency, EEG activity, and cerebrospinal fluid cytokine profile. Epilepsia 48(9):1739\u20131749","journal-title":"Epilepsia"},{"issue":"1","key":"8499_CR64","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.yebeh.2009.10.020","volume":"17","author":"MA Mikati","year":"2010","unstructured":"Mikati MA et al (2010) Intravenous immunoglobulin therapy in intractable childhood epilepsy: open-label study and review of the literature. Epilepsy Behav: E&B 17(1):90\u201394","journal-title":"Epilepsy Behav: E&B"},{"issue":"6","key":"8499_CR65","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1398-9995.1994.tb00833.x","volume":"49","author":"T Jakobsson","year":"1994","unstructured":"Jakobsson T et al (1994) Slight steroid-sparing effect of intravenous immunoglobulin in children and adolescents with moderately severe bronchial asthma. Allergy 49(6):413\u2013420","journal-title":"Allergy"},{"issue":"5","key":"8499_CR66","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/0091-6749(91)90420-S","volume":"87","author":"BD Mazer","year":"1991","unstructured":"Mazer BD, Gelfand EW (1991) An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma. J Allergy Clin Immunol 87(5):976\u2013983","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"8499_CR67","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1006\/clim.1999.4714","volume":"91","author":"JL Kishiyama","year":"1999","unstructured":"Kishiyama JL et al (1999) A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma. Clin Immunol 91(2):126\u2013133","journal-title":"Clin Immunol"},{"issue":"2","key":"8499_CR68","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1046\/j.1365-2222.1998.00214.x","volume":"28","author":"B Niggemann","year":"1998","unstructured":"Niggemann B et al (1998) Prospective, double-blind, placebo-controlled, multicentre study on the effect of high-dose, intravenous immunoglobulin in children and adolescents with severe bronchial asthma. Clin Exp Allergy 28(2):205\u2013210","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"8499_CR69","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1046\/j.1365-2133.2000.03377.x","volume":"142","author":"S Jolles","year":"2000","unstructured":"Jolles S, Hughes J, Rustin M (2000) The treatment of atopic dermatitis with adjunctive high-dose intravenous immunoglobulin: a report of three patients and review of the literature. Br J Dermatol 142(3):551\u2013554","journal-title":"Br J Dermatol"},{"issue":"2","key":"8499_CR70","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1081-1206(10)62802-5","volume":"81","author":"M Wakim","year":"1998","unstructured":"Wakim M et al (1998) High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. Ann Allergy Asthma Immunol 81(2):153\u2013158","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"8","key":"8499_CR71","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0167-5699(98)01285-7","volume":"19","author":"M Grewe","year":"1998","unstructured":"Grewe M et al (1998) A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 19(8):359\u2013361","journal-title":"Immunol Today"},{"issue":"2","key":"8499_CR72","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4168\/aair.2011.3.2.89","volume":"3","author":"SJ Jee","year":"2011","unstructured":"Jee SJ et al (2011) Long-term efficacy of intravenous immunoglobulin therapy for moderate to severe childhood atopic dermatitis. Allergy Asthma Immunol Res 3(2):89\u201395","journal-title":"Allergy Asthma Immunol Res"},{"issue":"6","key":"8499_CR73","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/00015550310020549","volume":"83","author":"S Jolles","year":"2003","unstructured":"Jolles S et al (2003) Adjunctive high-dose intravenous immunoglobulin treatment for resistant atopic dermatitis: efficacy and effects on intracellular cytokine levels and CD4 counts. Acta Derm Venereol 83(6):433\u2013437","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"8499_CR74","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0022-3476(05)83332-3","volume":"117","author":"L Bentur","year":"1990","unstructured":"Bentur L et al (1990) Advanced lung disease in a patient with cystic fibrosis and hypogammaglobulinemia: response to intravenous immune globulin therapy. J Pediatr 117(5):741\u2013743","journal-title":"J Pediatr"},{"issue":"5","key":"8499_CR75","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1056\/NEJM198001313020501","volume":"302","author":"WJ Matthews Jr","year":"1980","unstructured":"Matthews WJ Jr et al (1980) Hypogammaglobulinemia in patients with cystic fibrosis. N Engl J Med 302(5):245\u2013249","journal-title":"N Engl J Med"},{"issue":"5","key":"8499_CR76","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0022-3476(84)80946-4","volume":"104","author":"WB Wheeler","year":"1984","unstructured":"Wheeler WB et al (1984) Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study. J Pediatr 104(5):695\u2013699","journal-title":"J Pediatr"},{"issue":"1","key":"8499_CR77","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1089\/cap.2014.0067","volume":"25","author":"M Kovacevic","year":"2015","unstructured":"Kovacevic M, Grant P, Swedo SE (2015) Use of intravenous immunoglobulin in the treatment of twelve youths with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J Child Adolesc Psychopharmacol 25(1):65\u201369","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"9185","key":"8499_CR78","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0140-6736(99)00204-4","volume":"354","author":"HS Singer","year":"1999","unstructured":"Singer HS (1999) PANDAS and immunomodulatory therapy. Lancet 354(9185):1137\u20131138","journal-title":"Lancet"},{"issue":"9185","key":"8499_CR79","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S0140-6736(98)12297-3","volume":"354","author":"SJ Perlmutter","year":"1999","unstructured":"Perlmutter SJ et al (1999) Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 354(9185):1153\u20131158","journal-title":"Lancet"},{"key":"8499_CR80","unstructured":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Text Revision (DSM-IV-TR). 2000, American Psychiatric Association"},{"issue":"3","key":"8499_CR81","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/088307389901400314","volume":"14","author":"S Gupta","year":"1999","unstructured":"Gupta S (1999) Treatment of children with autism with intravenous immunoglobulin. J Child Neurol 14(3):203\u2013205","journal-title":"J Child Neurol"},{"issue":"4","key":"8499_CR82","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/BF02172828","volume":"26","author":"S Gupta","year":"1996","unstructured":"Gupta S, Aggarwal S, Heads C (1996) Dysregulated immune system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics. J Autism Dev Disord 26(4):439\u2013452","journal-title":"J Autism Dev Disord"},{"issue":"5","key":"8499_CR83","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1023\/A:1005568027292","volume":"30","author":"S Gupta","year":"2000","unstructured":"Gupta S (2000) Immunological treatments for autism. J Autism Dev Disord 30(5):475\u2013479","journal-title":"J Autism Dev Disord"},{"issue":"2","key":"8499_CR84","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/088307389801300207","volume":"13","author":"AV Plioplys","year":"1998","unstructured":"Plioplys AV (1998) Intravenous immunoglobulin treatment of children with autism. J Child Neurol 13(2):79\u201382","journal-title":"J Child Neurol"},{"issue":"2","key":"8499_CR85","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1023\/A:1023096728131","volume":"29","author":"G DelGiudice-Asch","year":"1999","unstructured":"DelGiudice-Asch G et al (1999) Brief report: a pilot open clinical trial of intravenous immunoglobulin in childhood autism. J Autism Dev Disord 29(2):157\u2013160","journal-title":"J Autism Dev Disord"},{"key":"8499_CR86","volume":"4","author":"P Raanani","year":"2008","unstructured":"Raanani P et al (2008) Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation. Cochrane Database Syst Rev 4, CD006501","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"8499_CR87","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/sj.bmt.1701742","volume":"23","author":"A Abdel-Mageed","year":"1999","unstructured":"Abdel-Mageed A et al (1999) Comparison of two doses of intravenous immunoglobulin after allogeneic bone marrow transplants. Bone Marrow Transplant 23(9):929\u2013932","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"8499_CR88","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1399-3046.2008.01120.x","volume":"14","author":"K Krampe","year":"2010","unstructured":"Krampe K et al (2010) The value of immunoprophylaxis for cytomegalovirus infection with intravenous immunoglobulin in pediatric liver transplant recipients receiving a low-dose immunosupressive regimen. Pediatr Transplant 14(1):67\u201371","journal-title":"Pediatr Transplant"},{"issue":"1","key":"8499_CR89","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1111\/j.1399-3046.2010.01384.x","volume":"16","author":"EI Anyaegbu","year":"2012","unstructured":"Anyaegbu EI et al (2012) Intravenous immunoglobulin therapy in the treatment of BK viremia and nephropathy in pediatric renal transplant recipients. Pediatr Transplant 16(1):E19\u2013E24","journal-title":"Pediatr Transplant"},{"issue":"1","key":"8499_CR90","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/1756285614563056","volume":"8","author":"RD Hadden","year":"2015","unstructured":"Hadden RD, Marreno F (2015) Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction. Ther Adv Neurol Disord 8(1):14\u201319","journal-title":"Ther Adv Neurol Disord"},{"issue":"12","key":"8499_CR91","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.autrev.2014.08.018","volume":"13","author":"MG Danieli","year":"2014","unstructured":"Danieli MG et al (2014) Subcutaneous IgG in immune-mediate diseases: proposed mechanisms of action and literature review. Autoimmunity Rev 13(12):1182\u20131188","journal-title":"Autoimmunity Rev"},{"issue":"3","key":"8499_CR92","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.autrev.2010.09.004","volume":"10","author":"MG Danieli","year":"2011","unstructured":"Danieli MG et al (2011) Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. Autoimmunity Rev 10(3):144\u2013149","journal-title":"Autoimmunity Rev"},{"issue":"7","key":"8499_CR93","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s10072-014-1632-9","volume":"35","author":"C Lazzaro","year":"2014","unstructured":"Lazzaro C, Lopiano L, Cocito D (2014) Subcutaneous vs intravenous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy: an Italian cost-minimization analysis. Neurol Sci: Off J Italian Neurol Soc Italian Soc Clin Neurophysiology 35(7):1023\u20131034","journal-title":"Neurol Sci: Off J Italian Neurol Soc Italian Soc Clin Neurophysiology"},{"issue":"1","key":"8499_CR94","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2217\/imt.13.146","volume":"6","author":"M Berger","year":"2014","unstructured":"Berger M (2014) Subcutaneous IgG in neurologic diseases. Immunotherapy 6(1):71\u201383","journal-title":"Immunotherapy"},{"issue":"5","key":"8499_CR95","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/mus.24554","volume":"51","author":"YA Rajabally","year":"2015","unstructured":"Rajabally YA (2015) Long-term immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 51(5):657\u2013661","journal-title":"Muscle Nerve"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8499-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-015-8499-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8499-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8499-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:11:11Z","timestamp":1744150271000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-015-8499-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,4]]},"references-count":95,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["8499"],"URL":"https:\/\/doi.org\/10.1007\/s12016-015-8499-2","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,4]]},"assertion":[{"value":"4 July 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}